Mariner’s Agilon Health AGL Stock Holding History

Mariner’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.31M	Sell	21,503 -2,213	-9%	-$145K	﹤0.01%	1409
2026 Q1	$179K	Buy	23,716 +14,175	+149%	+$229K	﹤0.01%	3196
2025 Q4	$166K	Buy	9,541 +7,760	+436%	+$150K	﹤0.01%	3225
2025 Q3	$45.9K	Sell	1,781 -6,349	-78%	-$240K	﹤0.01%	3456
2025 Q2	$467K	Buy	8,130 +2,802	+53%	+$225K	﹤0.01%	2386
2025 Q1	$577K	Buy	5,328 +3,211	+152%	+$279K	﹤0.01%	2093
2024 Q4	$101K	Sell	2,117 -630	-23%	-$38.1K	﹤0.01%	3188
2024 Q3	$270K	Sell	2,747 -1,466	-35%	-$189K	﹤0.01%	2666
2024 Q2	$689K	Sell	4,213 -120	-3%	-$17.1K	﹤0.01%	1787
2024 Q1	$661K	Buy	4,333 +1,180	+37%	+$196K	﹤0.01%	1822
2023 Q4	$989K	Sell	3,153 -739	-19%	-$267K	﹤0.01%	1437
2023 Q3	$1.73M	Buy	3,892 +1,521	+64%	+$687K	﹤0.01%	1036
2023 Q2	$1.03M	Buy	+2,371	New	+$1.33M	﹤0.01%	1293

Other funds holding AGL

CDR

Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

NPCM

North Peak Capital Management New York $900M AUM 193.67% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Mariner's AGL Position: Q2 2026 in Review

Mariner reduced its Agilon Health (AGL) stake by 9.3% in Q2 2026, selling an estimated $145K and leaving 21,503 shares worth $2.31M. The position accounts for ﹤0.01% of the portfolio, ranked #1409.

Mariner first reported a position in AGL in Q2 2023 and has held it in 13 quarters since. 179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

Mariner held 21,503 shares of Agilon Health worth $2.31M as of Q2 2026.
Mariner sold 2,213 Agilon Health shares in Q2 2026, an estimated $145K.
Agilon Health made up ﹤0.01% of Mariner's portfolio in Q2 2026, its #1409 holding.
Mariner first reported a position in Agilon Health in Q2 2023 and has held it in 13 quarters since.
179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.